Tuesday, May 19, 2026

2:45 PM - 3:30 PM

---

Details

Building a life sciences company today requires more than a compelling narrative—it demands clear, credible proof of growth. As capital markets become increasingly selective, expectations around commercial traction, strategic execution and market readiness have shifted. This session brings together leaders from scaling companies alongside market-facing investors and analysts to explore what “scaling” really means in practice. From private growth through to listed environments, the discussion will examine how credibility is established, what signals the market is truly responding to, and where companies most often fall short. With perspectives spanning operators and capital markets, this conversation will unpack the gap between the story companies tell and the evidence investors now expect—offering practical insights into what it takes to build, sustain and demonstrate momentum in today’s environment.

---

Speaker